This phenotype has been ascribed to restore insulinsensitivity through insulin receptor (IR) and insulin receptorsubstrate (IRS1) in the absence of PTP1B, thus projecting theimportance of PTP1B as drug target for diabetes and obesity [35][36]. The gene discussed is PTPN1; the disease is obesity due to melanocortin 4 receptor deficiency.